Investigation of COVID-19 infection in subjects with Klinefelter syndrome.
J Endocrinol Invest
; 45(5): 1065-1069, 2022 May.
Article
em En
| MEDLINE
| ID: mdl-35064538
ABSTRACT
PURPOSE:
COVID-19 has worse clinical outcomes in males compared with females and testosterone may determine gender differences. Hypogonadism and supernumerary X chromosome may have a role in the SARS-CoV-2 infection in Klinefelter syndrome (KS). Aim of the study was evaluating COVID-19 frequency and severity in KS.METHODS:
Participants were invited to complete a retrospective self-administered questionnaire containing multiple choice and open-ended answers.RESULTS:
COVID-19 was detected in 10% of the evaluated KS subjects; none was hospitalized. 44.4% of COVID-19 patients had one cohabitant-infected versus 3% of non-infected (p < 0.01). Testosterone levels in infected patients were lower compared to those of non-infected subjects (3.1 ± 1.2 ng/ml vs. 5.2 ± 2 ng/ml, p < 0.05).CONCLUSIONS:
The frequency of SARS-CoV-2 infection among KS subjects was 10%. All infected patients showed mild symptoms. The presence of one affected cohabitant significantly associated with SARS-CoV-2 infection. An association between SARS-CoV-2 and hypogonadism was confirmed.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
COVID-19
/
Hipogonadismo
/
Síndrome de Klinefelter
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article